Newsletter | January 20, 2026
FEATURED EDITORIAL
Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving?
By Anke Rosch, Boehringer Ingelheim Pharma GmbH & Co. KG
What can we do preclinically for drug-induced impairment of driving ability? This article reviews the causes, regulatory environment, and limitations.
MOST POPULAR NEWS
•
CancerIQ Unveils A Risk-Based Early Cancer Detection Program For Imaging & Diagnostics
Labcorp Expands MRD Testing For Breast, Lung And Colon Cancer Recurrence Risk
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA
Truvian Health Rapidly Expands TruVerus Menu With FDA Clearances
10x Genomics To Advance Research In Diag Apps Of Tumor Single Cell & Spatial Profiling
Synthego Announces Entry Into Molecular Biology And Clinical Diagnostic Reagents Market
Alamar Biosciences Announces Launch Of NULISAqpcr AD 5-plex Assay
Freenome Announces Expanded AI & Deep Learning Initiatives Accelerated By NVIDIA
HCAP Partners Announces Follow-On Acquisition For IDS With The Addition Of Core
Affidea Acquires A Majority Stake In LabPoint From Lindenhofgruppe
Alpenglow Biosciences & PathNet Partner To Advance National Platform For 3D AI Cancer Diagnostics
